News and Trends 11 Apr 2023
Intracellular drug delivery startup Vitarka Therapeutics raises £1.27M
Vitarka Therapeutics, which focuses on non-viral drug delivery technology, has raised £1.27 million ($1.58 million) in equity from venture capital firm SOSV, the UK Innovation & Science Seed Fund (UK12S)…
